Leidos Holdings (LDOS) has secured a new five year, US$301 million contract to monitor U.S. military networks around the clock. The work extends its role in cyber defense for the Department of War.
See our latest analysis for Leidos Holdings.
At a share price of US$141.39, Leidos Holdings has seen a 30 day share price return of 26.08% and a 90 day share price return of 10.36%, while the 1 year total shareholder return is down 21.33% but up just over 50% across three and five years. This points to long term holders still being ahead even as recent momentum has weakened earlier in the year and then picked up again around contracts like this one.
If this contract has you thinking about where digital infrastructure and defense related spending could flow next, it may be worth scanning a curated list of 39 power grid technology and infrastructure stocks
Bulls argue Leidos Holdings deserves a richer multiple after the contract win and long term shareholder gains. Bears see a sharp rebound after a weak year and question how much is already in the price. The valuation numbers give clues next.
Most Popular Narrative: 9.7% Undervalued
Leidos Holdings closed at $141.39, while the most followed narrative assigns a fair value of $156.60 and uses a discount rate of 8.06% to get there.
Accelerating customer demand for digital modernization, AI-powered solutions, and autonomous systems in defense, healthcare, and intelligence plays to Leidos' strengths and is leading to higher-quality, higher-margin contracts that improve net margins, as these capabilities command premium pricing and are in areas of secular growth.
Read the complete narrative. Read the complete narrative.
Curious what justifies that fair value gap? The narrative leans on steady revenue expansion, resilient margins and a future earnings multiple below many current sector peers. The interesting part is how those ingredients are combined.
Result: Fair Value of $156.60 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Leidos Holdings still faces concentration in U.S. federal contracts and ongoing Health segment pressure. These factors could challenge earnings assumptions if funding priorities or contract terms shift.
Find out about the key risks to this Leidos Holdings narrative.
Next Steps
With both optimism around Leidos Holdings and clear concerns in the mix, it makes sense to move quickly and test the numbers yourself. To weigh up both sides in one place, review the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Leidos Holdings?
If you want to keep your momentum going after looking at Leidos Holdings, use the screener to spot other opportunities that might fit your approach before markets move.
- Target potential mispricing by reviewing companies that appear fundamentally sound yet possibly overlooked through the screener containing 18 high quality undiscovered gems.
- Prioritise strength by focusing on businesses with resilient finances using the solid balance sheet and fundamentals stocks screener (50 results).
- Seek a smoother ride by concentrating on companies with more stable profiles via the 75 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com